nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—LHCGR—neck—skin cancer	0.0262	0.355	CbGeAlD
Goserelin—LHCGR—Ovarian Infertility Genes—MLH1—skin cancer	0.0189	0.11	CbGpPWpGaD
Goserelin—LHCGR—connective tissue—skin cancer	0.0188	0.254	CbGeAlD
Goserelin—LHCGR—Peptide GPCRs—MC1R—skin cancer	0.0142	0.0827	CbGpPWpGaD
Goserelin—LHCGR—female reproductive system—skin cancer	0.0132	0.179	CbGeAlD
Goserelin—LHCGR—Ovarian Infertility Genes—CDK4—skin cancer	0.00963	0.0561	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—MC1R—skin cancer	0.00949	0.0553	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—MC1R—skin cancer	0.00938	0.0547	CbGpPWpGaD
Goserelin—GNRHR—female reproductive system—skin cancer	0.00853	0.115	CbGeAlD
Goserelin—GNRHR—head—skin cancer	0.00713	0.0965	CbGeAlD
Goserelin—LHCGR—G alpha (s) signalling events—PTGER4—skin cancer	0.00617	0.036	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—SMO—skin cancer	0.00543	0.0317	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.00522	0.0304	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—PTCH2—skin cancer	0.00471	0.0275	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00447	0.0261	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00343	0.02	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—MC1R—skin cancer	0.00341	0.0199	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—PTCH2—skin cancer	0.00315	0.0184	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00299	0.0175	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00294	0.0171	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RHOU—skin cancer	0.00292	0.0171	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—SHH—skin cancer	0.00243	0.0142	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PTCH2—skin cancer	0.00242	0.0141	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—SMO—skin cancer	0.0023	0.0134	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—PTCH1—skin cancer	0.0023	0.0134	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—MC1R—skin cancer	0.00228	0.0133	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—PTGER4—skin cancer	0.00224	0.0131	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00197	0.0115	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RHOU—skin cancer	0.00196	0.0114	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—MC1R—skin cancer	0.00193	0.0112	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—MC1R—skin cancer	0.00175	0.0102	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—SHH—skin cancer	0.00162	0.00947	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PTCH2—skin cancer	0.00162	0.00944	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—PTCH1—skin cancer	0.00154	0.00898	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—SMO—skin cancer	0.00154	0.00898	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—PTGER4—skin cancer	0.0015	0.00874	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTCH2—skin cancer	0.00143	0.00833	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—MC1R—skin cancer	0.00129	0.00751	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PTGER4—skin cancer	0.00127	0.00738	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—SHH—skin cancer	0.00125	0.00726	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PTCH1—skin cancer	0.00118	0.00688	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—SMO—skin cancer	0.00118	0.00688	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MC1R—skin cancer	0.00117	0.00682	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PTGER4—skin cancer	0.00115	0.0067	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GLI2—skin cancer	0.00108	0.00631	CbGpPWpGaD
Goserelin—Migraine—Docetaxel—skin cancer	0.00105	0.0014	CcSEcCtD
Goserelin—Urticaria—Imiquimod—skin cancer	0.00105	0.00139	CcSEcCtD
Goserelin—Abdominal pain—Imiquimod—skin cancer	0.00104	0.00138	CcSEcCtD
Goserelin—Body temperature increased—Imiquimod—skin cancer	0.00104	0.00138	CcSEcCtD
Goserelin—Eye disorder—Temozolomide—skin cancer	0.00104	0.00138	CcSEcCtD
Goserelin—Malaise—Bleomycin—skin cancer	0.00104	0.00137	CcSEcCtD
Goserelin—Cardiac disorder—Temozolomide—skin cancer	0.00103	0.00137	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—MC1R—skin cancer	0.00103	0.00602	CbGpPWpGaD
Goserelin—Haemoglobin—Fluorouracil—skin cancer	0.00103	0.00137	CcSEcCtD
Goserelin—Leukopenia—Bleomycin—skin cancer	0.00103	0.00136	CcSEcCtD
Goserelin—Rhinitis—Fluorouracil—skin cancer	0.00103	0.00136	CcSEcCtD
Goserelin—Haemorrhage—Fluorouracil—skin cancer	0.00103	0.00136	CcSEcCtD
Goserelin—Dizziness—Vemurafenib—skin cancer	0.00102	0.00136	CcSEcCtD
Goserelin—Pharyngitis—Fluorouracil—skin cancer	0.00102	0.00135	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—GLI1—skin cancer	0.00102	0.00593	CbGpPWpGaD
Goserelin—Angiopathy—Temozolomide—skin cancer	0.00101	0.00134	CcSEcCtD
Goserelin—Immune system disorder—Temozolomide—skin cancer	0.00101	0.00133	CcSEcCtD
Goserelin—Cough—Bleomycin—skin cancer	0.001	0.00133	CcSEcCtD
Goserelin—Chills—Temozolomide—skin cancer	0.001	0.00133	CcSEcCtD
Goserelin—Ill-defined disorder—Dactinomycin—skin cancer	0.000995	0.00132	CcSEcCtD
Goserelin—Anaemia—Dactinomycin—skin cancer	0.000991	0.00131	CcSEcCtD
Goserelin—Vomiting—Vemurafenib—skin cancer	0.000985	0.00131	CcSEcCtD
Goserelin—Alopecia—Temozolomide—skin cancer	0.000985	0.00131	CcSEcCtD
Goserelin—Dry skin—Docetaxel—skin cancer	0.000982	0.0013	CcSEcCtD
Goserelin—Chest pain—Bleomycin—skin cancer	0.000979	0.0013	CcSEcCtD
Goserelin—Myalgia—Bleomycin—skin cancer	0.000979	0.0013	CcSEcCtD
Goserelin—Rash—Vemurafenib—skin cancer	0.000977	0.00129	CcSEcCtD
Goserelin—Mental disorder—Temozolomide—skin cancer	0.000976	0.00129	CcSEcCtD
Goserelin—Dermatitis—Vemurafenib—skin cancer	0.000976	0.00129	CcSEcCtD
Goserelin—Hypersensitivity—Imiquimod—skin cancer	0.000973	0.00129	CcSEcCtD
Goserelin—Headache—Vemurafenib—skin cancer	0.000971	0.00129	CcSEcCtD
Goserelin—Malnutrition—Temozolomide—skin cancer	0.00097	0.00129	CcSEcCtD
Goserelin—Erythema—Temozolomide—skin cancer	0.00097	0.00129	CcSEcCtD
Goserelin—Breast disorder—Docetaxel—skin cancer	0.000968	0.00128	CcSEcCtD
Goserelin—Discomfort—Bleomycin—skin cancer	0.000967	0.00128	CcSEcCtD
Goserelin—Malaise—Dactinomycin—skin cancer	0.000967	0.00128	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—SUFU—skin cancer	0.000965	0.00563	CbGpPWpGaD
Goserelin—Leukopenia—Dactinomycin—skin cancer	0.00096	0.00127	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PTCH2—skin cancer	0.000956	0.00557	CbGpPWpGaD
Goserelin—Asthenia—Imiquimod—skin cancer	0.000948	0.00126	CcSEcCtD
Goserelin—Confusional state—Bleomycin—skin cancer	0.000946	0.00125	CcSEcCtD
Goserelin—Anaphylactic shock—Bleomycin—skin cancer	0.000939	0.00124	CcSEcCtD
Goserelin—Oedema—Bleomycin—skin cancer	0.000939	0.00124	CcSEcCtD
Goserelin—Back pain—Temozolomide—skin cancer	0.000938	0.00124	CcSEcCtD
Goserelin—Pruritus—Imiquimod—skin cancer	0.000935	0.00124	CcSEcCtD
Goserelin—Infection—Bleomycin—skin cancer	0.000932	0.00124	CcSEcCtD
Goserelin—Nausea—Vemurafenib—skin cancer	0.00092	0.00122	CcSEcCtD
Goserelin—Thrombocytopenia—Bleomycin—skin cancer	0.000919	0.00122	CcSEcCtD
Goserelin—Arrhythmia—Fluorouracil—skin cancer	0.000917	0.00122	CcSEcCtD
Goserelin—Vision blurred—Temozolomide—skin cancer	0.000914	0.00121	CcSEcCtD
Goserelin—Myalgia—Dactinomycin—skin cancer	0.000913	0.00121	CcSEcCtD
Goserelin—Alopecia—Fluorouracil—skin cancer	0.000907	0.0012	CcSEcCtD
Goserelin—Diarrhoea—Imiquimod—skin cancer	0.000904	0.0012	CcSEcCtD
Goserelin—Discomfort—Dactinomycin—skin cancer	0.000902	0.0012	CcSEcCtD
Goserelin—Angina pectoris—Docetaxel—skin cancer	0.000902	0.0012	CcSEcCtD
Goserelin—Ill-defined disorder—Temozolomide—skin cancer	0.0009	0.00119	CcSEcCtD
Goserelin—Anaemia—Temozolomide—skin cancer	0.000897	0.00119	CcSEcCtD
Goserelin—Anorexia—Bleomycin—skin cancer	0.000895	0.00119	CcSEcCtD
Goserelin—Erythema—Fluorouracil—skin cancer	0.000894	0.00118	CcSEcCtD
Goserelin—Hypotension—Bleomycin—skin cancer	0.000877	0.00116	CcSEcCtD
Goserelin—Oedema—Dactinomycin—skin cancer	0.000875	0.00116	CcSEcCtD
Goserelin—Malaise—Temozolomide—skin cancer	0.000875	0.00116	CcSEcCtD
Goserelin—Dizziness—Imiquimod—skin cancer	0.000874	0.00116	CcSEcCtD
Goserelin—Infection—Dactinomycin—skin cancer	0.00087	0.00115	CcSEcCtD
Goserelin—Leukopenia—Temozolomide—skin cancer	0.000868	0.00115	CcSEcCtD
Goserelin—Palpitations—Temozolomide—skin cancer	0.000857	0.00114	CcSEcCtD
Goserelin—Thrombocytopenia—Dactinomycin—skin cancer	0.000857	0.00114	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000855	0.00113	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—PTGER4—skin cancer	0.000847	0.00494	CbGpPWpGaD
Goserelin—Cough—Temozolomide—skin cancer	0.000847	0.00112	CcSEcCtD
Goserelin—Paraesthesia—Bleomycin—skin cancer	0.000843	0.00112	CcSEcCtD
Goserelin—Weight increased—Docetaxel—skin cancer	0.000843	0.00112	CcSEcCtD
Goserelin—Vision blurred—Fluorouracil—skin cancer	0.000842	0.00112	CcSEcCtD
Goserelin—Convulsion—Temozolomide—skin cancer	0.000841	0.00111	CcSEcCtD
Goserelin—Vomiting—Imiquimod—skin cancer	0.00084	0.00111	CcSEcCtD
Goserelin—Hypertension—Temozolomide—skin cancer	0.000838	0.00111	CcSEcCtD
Goserelin—Dyspnoea—Bleomycin—skin cancer	0.000837	0.00111	CcSEcCtD
Goserelin—Anorexia—Dactinomycin—skin cancer	0.000834	0.00111	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—SHH—skin cancer	0.000834	0.00486	CbGpPWpGaD
Goserelin—Rash—Imiquimod—skin cancer	0.000833	0.0011	CcSEcCtD
Goserelin—Dermatitis—Imiquimod—skin cancer	0.000832	0.0011	CcSEcCtD
Goserelin—Pneumonia—Docetaxel—skin cancer	0.00083	0.0011	CcSEcCtD
Goserelin—Headache—Imiquimod—skin cancer	0.000828	0.0011	CcSEcCtD
Goserelin—Anaemia—Fluorouracil—skin cancer	0.000826	0.00109	CcSEcCtD
Goserelin—Myalgia—Temozolomide—skin cancer	0.000826	0.00109	CcSEcCtD
Goserelin—Arthralgia—Temozolomide—skin cancer	0.000826	0.00109	CcSEcCtD
Goserelin—Anxiety—Temozolomide—skin cancer	0.000823	0.00109	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00082	0.00109	CcSEcCtD
Goserelin—Discomfort—Temozolomide—skin cancer	0.000816	0.00108	CcSEcCtD
Goserelin—Decreased appetite—Bleomycin—skin cancer	0.000816	0.00108	CcSEcCtD
Goserelin—Acute coronary syndrome—Docetaxel—skin cancer	0.000814	0.00108	CcSEcCtD
Goserelin—Renal failure—Docetaxel—skin cancer	0.000812	0.00108	CcSEcCtD
Goserelin—Myocardial infarction—Docetaxel—skin cancer	0.000809	0.00107	CcSEcCtD
Goserelin—Dry mouth—Temozolomide—skin cancer	0.000808	0.00107	CcSEcCtD
Goserelin—Jaundice—Docetaxel—skin cancer	0.000805	0.00107	CcSEcCtD
Goserelin—Pain—Bleomycin—skin cancer	0.000803	0.00106	CcSEcCtD
Goserelin—Leukopenia—Fluorouracil—skin cancer	0.0008	0.00106	CcSEcCtD
Goserelin—Confusional state—Temozolomide—skin cancer	0.000798	0.00106	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000798	0.00106	CcSEcCtD
Goserelin—Oedema—Temozolomide—skin cancer	0.000792	0.00105	CcSEcCtD
Goserelin—Anaphylactic shock—Temozolomide—skin cancer	0.000792	0.00105	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—SMO—skin cancer	0.000791	0.00461	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PTCH1—skin cancer	0.000791	0.00461	CbGpPWpGaD
Goserelin—Infection—Temozolomide—skin cancer	0.000787	0.00104	CcSEcCtD
Goserelin—Nausea—Imiquimod—skin cancer	0.000785	0.00104	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000781	0.00455	CbGpPWpGaD
Goserelin—Epistaxis—Docetaxel—skin cancer	0.000779	0.00103	CcSEcCtD
Goserelin—Nervous system disorder—Temozolomide—skin cancer	0.000776	0.00103	CcSEcCtD
Goserelin—Thrombocytopenia—Temozolomide—skin cancer	0.000775	0.00103	CcSEcCtD
Goserelin—Convulsion—Fluorouracil—skin cancer	0.000774	0.00103	CcSEcCtD
Goserelin—Feeling abnormal—Bleomycin—skin cancer	0.000773	0.00103	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—PTGER4—skin cancer	0.00077	0.00449	CbGpPWpGaD
Goserelin—Skin disorder—Temozolomide—skin cancer	0.000769	0.00102	CcSEcCtD
Goserelin—Hyperhidrosis—Temozolomide—skin cancer	0.000765	0.00101	CcSEcCtD
Goserelin—Chest pain—Fluorouracil—skin cancer	0.000761	0.00101	CcSEcCtD
Goserelin—Myalgia—Fluorouracil—skin cancer	0.000761	0.00101	CcSEcCtD
Goserelin—Decreased appetite—Dactinomycin—skin cancer	0.000761	0.00101	CcSEcCtD
Goserelin—Fatigue—Dactinomycin—skin cancer	0.000755	0.001	CcSEcCtD
Goserelin—Anorexia—Temozolomide—skin cancer	0.000755	0.001	CcSEcCtD
Goserelin—Discomfort—Fluorouracil—skin cancer	0.000752	0.000996	CcSEcCtD
Goserelin—Pain—Dactinomycin—skin cancer	0.000749	0.000992	CcSEcCtD
Goserelin—Urticaria—Bleomycin—skin cancer	0.000746	0.000988	CcSEcCtD
Goserelin—Haemoglobin—Docetaxel—skin cancer	0.000745	0.000987	CcSEcCtD
Goserelin—Rhinitis—Docetaxel—skin cancer	0.000743	0.000985	CcSEcCtD
Goserelin—Body temperature increased—Bleomycin—skin cancer	0.000742	0.000983	CcSEcCtD
Goserelin—Haemorrhage—Docetaxel—skin cancer	0.000741	0.000982	CcSEcCtD
Goserelin—Hepatitis—Docetaxel—skin cancer	0.000741	0.000982	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—SHH—skin cancer	0.000736	0.00429	CbGpPWpGaD
Goserelin—Confusional state—Fluorouracil—skin cancer	0.000736	0.000975	CcSEcCtD
Goserelin—Pharyngitis—Docetaxel—skin cancer	0.000736	0.000975	CcSEcCtD
Goserelin—Urinary tract disorder—Docetaxel—skin cancer	0.000732	0.00097	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—RASA1—skin cancer	0.000731	0.00426	CbGpPWpGaD
Goserelin—Oedema peripheral—Docetaxel—skin cancer	0.00073	0.000968	CcSEcCtD
Goserelin—Anaphylactic shock—Fluorouracil—skin cancer	0.000729	0.000967	CcSEcCtD
Goserelin—Oedema—Fluorouracil—skin cancer	0.000729	0.000967	CcSEcCtD
Goserelin—Urethral disorder—Docetaxel—skin cancer	0.000726	0.000963	CcSEcCtD
Goserelin—Infection—Fluorouracil—skin cancer	0.000725	0.00096	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—GLI2—skin cancer	0.000725	0.00422	CbGpPWpGaD
Goserelin—Feeling abnormal—Dactinomycin—skin cancer	0.000721	0.000956	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000721	0.000956	CcSEcCtD
Goserelin—Insomnia—Temozolomide—skin cancer	0.000716	0.000949	CcSEcCtD
Goserelin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000716	0.000949	CcSEcCtD
Goserelin—Nervous system disorder—Fluorouracil—skin cancer	0.000715	0.000948	CcSEcCtD
Goserelin—Thrombocytopenia—Fluorouracil—skin cancer	0.000714	0.000947	CcSEcCtD
Goserelin—Tachycardia—Fluorouracil—skin cancer	0.000712	0.000944	CcSEcCtD
Goserelin—Paraesthesia—Temozolomide—skin cancer	0.000711	0.000942	CcSEcCtD
Goserelin—Dyspnoea—Temozolomide—skin cancer	0.000706	0.000935	CcSEcCtD
Goserelin—Somnolence—Temozolomide—skin cancer	0.000704	0.000933	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—SMO—skin cancer	0.000698	0.00407	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTCH1—skin cancer	0.000698	0.00407	CbGpPWpGaD
Goserelin—Dyspepsia—Temozolomide—skin cancer	0.000697	0.000924	CcSEcCtD
Goserelin—Anorexia—Fluorouracil—skin cancer	0.000695	0.000922	CcSEcCtD
Goserelin—Eye disorder—Docetaxel—skin cancer	0.000693	0.000918	CcSEcCtD
Goserelin—Abdominal pain—Dactinomycin—skin cancer	0.000692	0.000917	CcSEcCtD
Goserelin—Body temperature increased—Dactinomycin—skin cancer	0.000692	0.000917	CcSEcCtD
Goserelin—Hypersensitivity—Bleomycin—skin cancer	0.000692	0.000916	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—MC1R—skin cancer	0.000691	0.00403	CbGpPWpGaD
Goserelin—Decreased appetite—Temozolomide—skin cancer	0.000688	0.000912	CcSEcCtD
Goserelin—Cardiac disorder—Docetaxel—skin cancer	0.000688	0.000911	CcSEcCtD
Goserelin—Fatigue—Temozolomide—skin cancer	0.000683	0.000905	CcSEcCtD
Goserelin—Hypotension—Fluorouracil—skin cancer	0.000682	0.000903	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—GLI1—skin cancer	0.000681	0.00397	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTGER4—skin cancer	0.000679	0.00396	CbGpPWpGaD
Goserelin—Pain—Temozolomide—skin cancer	0.000677	0.000897	CcSEcCtD
Goserelin—Constipation—Temozolomide—skin cancer	0.000677	0.000897	CcSEcCtD
Goserelin—Asthenia—Bleomycin—skin cancer	0.000673	0.000892	CcSEcCtD
Goserelin—Angiopathy—Docetaxel—skin cancer	0.000672	0.000891	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000672	0.00392	CbGpPWpGaD
Goserelin—Immune system disorder—Docetaxel—skin cancer	0.000669	0.000887	CcSEcCtD
Goserelin—Chills—Docetaxel—skin cancer	0.000665	0.000881	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000665	0.000881	CcSEcCtD
Goserelin—Pruritus—Bleomycin—skin cancer	0.000664	0.00088	CcSEcCtD
Goserelin—Arrhythmia—Docetaxel—skin cancer	0.000662	0.000877	CcSEcCtD
Goserelin—Insomnia—Fluorouracil—skin cancer	0.00066	0.000874	CcSEcCtD
Goserelin—Paraesthesia—Fluorouracil—skin cancer	0.000655	0.000868	CcSEcCtD
Goserelin—Alopecia—Docetaxel—skin cancer	0.000655	0.000868	CcSEcCtD
Goserelin—Feeling abnormal—Temozolomide—skin cancer	0.000652	0.000865	CcSEcCtD
Goserelin—Dyspnoea—Fluorouracil—skin cancer	0.00065	0.000862	CcSEcCtD
Goserelin—Mental disorder—Docetaxel—skin cancer	0.000649	0.00086	CcSEcCtD
Goserelin—Somnolence—Fluorouracil—skin cancer	0.000649	0.000859	CcSEcCtD
Goserelin—Gastrointestinal pain—Temozolomide—skin cancer	0.000647	0.000858	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—SUFU—skin cancer	0.000646	0.00377	CbGpPWpGaD
Goserelin—Malnutrition—Docetaxel—skin cancer	0.000645	0.000855	CcSEcCtD
Goserelin—Erythema—Docetaxel—skin cancer	0.000645	0.000855	CcSEcCtD
Goserelin—Hypersensitivity—Dactinomycin—skin cancer	0.000645	0.000855	CcSEcCtD
Goserelin—Dyspepsia—Fluorouracil—skin cancer	0.000642	0.000851	CcSEcCtD
Goserelin—Decreased appetite—Fluorouracil—skin cancer	0.000634	0.00084	CcSEcCtD
Goserelin—Urticaria—Temozolomide—skin cancer	0.000629	0.000834	CcSEcCtD
Goserelin—Asthenia—Dactinomycin—skin cancer	0.000628	0.000832	CcSEcCtD
Goserelin—Abdominal pain—Temozolomide—skin cancer	0.000626	0.000829	CcSEcCtD
Goserelin—Body temperature increased—Temozolomide—skin cancer	0.000626	0.000829	CcSEcCtD
Goserelin—Back pain—Docetaxel—skin cancer	0.000624	0.000827	CcSEcCtD
Goserelin—Pain—Fluorouracil—skin cancer	0.000624	0.000827	CcSEcCtD
Goserelin—Muscle spasms—Docetaxel—skin cancer	0.00062	0.000822	CcSEcCtD
Goserelin—Feeling abnormal—Fluorouracil—skin cancer	0.000601	0.000797	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—FOXO4—skin cancer	0.0006	0.0035	CbGpPWpGaD
Goserelin—Diarrhoea—Dactinomycin—skin cancer	0.000599	0.000794	CcSEcCtD
Goserelin—Vomiting—Bleomycin—skin cancer	0.000597	0.000791	CcSEcCtD
Goserelin—Anaemia—Docetaxel—skin cancer	0.000596	0.00079	CcSEcCtD
Goserelin—Rash—Bleomycin—skin cancer	0.000592	0.000784	CcSEcCtD
Goserelin—Dermatitis—Bleomycin—skin cancer	0.000591	0.000784	CcSEcCtD
Goserelin—Hypersensitivity—Temozolomide—skin cancer	0.000583	0.000773	CcSEcCtD
Goserelin—Urticaria—Fluorouracil—skin cancer	0.00058	0.000768	CcSEcCtD
Goserelin—Leukopenia—Docetaxel—skin cancer	0.000577	0.000765	CcSEcCtD
Goserelin—Body temperature increased—Fluorouracil—skin cancer	0.000577	0.000764	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000571	0.00333	CbGpPWpGaD
Goserelin—Palpitations—Docetaxel—skin cancer	0.00057	0.000756	CcSEcCtD
Goserelin—Asthenia—Temozolomide—skin cancer	0.000568	0.000753	CcSEcCtD
Goserelin—Cough—Docetaxel—skin cancer	0.000563	0.000746	CcSEcCtD
Goserelin—Pruritus—Temozolomide—skin cancer	0.00056	0.000742	CcSEcCtD
Goserelin—Convulsion—Docetaxel—skin cancer	0.000559	0.000741	CcSEcCtD
Goserelin—Nausea—Bleomycin—skin cancer	0.000558	0.000739	CcSEcCtD
Goserelin—Hypertension—Docetaxel—skin cancer	0.000557	0.000738	CcSEcCtD
Goserelin—Vomiting—Dactinomycin—skin cancer	0.000557	0.000738	CcSEcCtD
Goserelin—Rash—Dactinomycin—skin cancer	0.000552	0.000731	CcSEcCtD
Goserelin—Arthralgia—Docetaxel—skin cancer	0.000549	0.000728	CcSEcCtD
Goserelin—Chest pain—Docetaxel—skin cancer	0.000549	0.000728	CcSEcCtD
Goserelin—Myalgia—Docetaxel—skin cancer	0.000549	0.000728	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000547	0.00319	CbGpPWpGaD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000545	0.000723	CcSEcCtD
Goserelin—Diarrhoea—Temozolomide—skin cancer	0.000542	0.000718	CcSEcCtD
Goserelin—Hypersensitivity—Fluorouracil—skin cancer	0.000537	0.000712	CcSEcCtD
Goserelin—Dry mouth—Docetaxel—skin cancer	0.000537	0.000712	CcSEcCtD
Goserelin—Confusional state—Docetaxel—skin cancer	0.000531	0.000704	CcSEcCtD
Goserelin—Oedema—Docetaxel—skin cancer	0.000527	0.000698	CcSEcCtD
Goserelin—Anaphylactic shock—Docetaxel—skin cancer	0.000527	0.000698	CcSEcCtD
Goserelin—Dizziness—Temozolomide—skin cancer	0.000524	0.000694	CcSEcCtD
Goserelin—Infection—Docetaxel—skin cancer	0.000523	0.000693	CcSEcCtD
Goserelin—Nausea—Dactinomycin—skin cancer	0.00052	0.000689	CcSEcCtD
Goserelin—Shock—Docetaxel—skin cancer	0.000518	0.000686	CcSEcCtD
Goserelin—Nervous system disorder—Docetaxel—skin cancer	0.000516	0.000684	CcSEcCtD
Goserelin—Pruritus—Fluorouracil—skin cancer	0.000516	0.000684	CcSEcCtD
Goserelin—Thrombocytopenia—Docetaxel—skin cancer	0.000516	0.000683	CcSEcCtD
Goserelin—Tachycardia—Docetaxel—skin cancer	0.000514	0.000681	CcSEcCtD
Goserelin—Skin disorder—Docetaxel—skin cancer	0.000511	0.000678	CcSEcCtD
Goserelin—Vomiting—Temozolomide—skin cancer	0.000503	0.000667	CcSEcCtD
Goserelin—Anorexia—Docetaxel—skin cancer	0.000502	0.000665	CcSEcCtD
Goserelin—Rash—Temozolomide—skin cancer	0.000499	0.000662	CcSEcCtD
Goserelin—Diarrhoea—Fluorouracil—skin cancer	0.000499	0.000661	CcSEcCtD
Goserelin—Dermatitis—Temozolomide—skin cancer	0.000499	0.000661	CcSEcCtD
Goserelin—Headache—Temozolomide—skin cancer	0.000496	0.000657	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—SHH—skin cancer	0.000493	0.00287	CbGpPWpGaD
Goserelin—Hypotension—Docetaxel—skin cancer	0.000492	0.000652	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—RASA1—skin cancer	0.00049	0.00285	CbGpPWpGaD
Goserelin—Dizziness—Fluorouracil—skin cancer	0.000482	0.000639	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00048	0.000636	CcSEcCtD
Goserelin—Insomnia—Docetaxel—skin cancer	0.000476	0.000631	CcSEcCtD
Goserelin—Paraesthesia—Docetaxel—skin cancer	0.000473	0.000627	CcSEcCtD
Goserelin—Nausea—Temozolomide—skin cancer	0.00047	0.000623	CcSEcCtD
Goserelin—Dyspnoea—Docetaxel—skin cancer	0.000469	0.000622	CcSEcCtD
Goserelin—Somnolence—Docetaxel—skin cancer	0.000468	0.00062	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PTCH1—skin cancer	0.000467	0.00272	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SMO—skin cancer	0.000467	0.00272	CbGpPWpGaD
Goserelin—Vomiting—Fluorouracil—skin cancer	0.000464	0.000615	CcSEcCtD
Goserelin—Dyspepsia—Docetaxel—skin cancer	0.000463	0.000614	CcSEcCtD
Goserelin—Rash—Fluorouracil—skin cancer	0.00046	0.00061	CcSEcCtD
Goserelin—Dermatitis—Fluorouracil—skin cancer	0.00046	0.000609	CcSEcCtD
Goserelin—Decreased appetite—Docetaxel—skin cancer	0.000458	0.000607	CcSEcCtD
Goserelin—Headache—Fluorouracil—skin cancer	0.000457	0.000606	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PTGER4—skin cancer	0.000455	0.00265	CbGpPWpGaD
Goserelin—Fatigue—Docetaxel—skin cancer	0.000454	0.000602	CcSEcCtD
Goserelin—Constipation—Docetaxel—skin cancer	0.00045	0.000597	CcSEcCtD
Goserelin—Pain—Docetaxel—skin cancer	0.00045	0.000597	CcSEcCtD
Goserelin—Feeling abnormal—Docetaxel—skin cancer	0.000434	0.000575	CcSEcCtD
Goserelin—Nausea—Fluorouracil—skin cancer	0.000433	0.000574	CcSEcCtD
Goserelin—Gastrointestinal pain—Docetaxel—skin cancer	0.000431	0.000571	CcSEcCtD
Goserelin—Abdominal pain—Docetaxel—skin cancer	0.000416	0.000552	CcSEcCtD
Goserelin—Body temperature increased—Docetaxel—skin cancer	0.000416	0.000552	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—FOXO4—skin cancer	0.000402	0.00234	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TERT—skin cancer	0.000401	0.00234	CbGpPWpGaD
Goserelin—Hypersensitivity—Docetaxel—skin cancer	0.000388	0.000514	CcSEcCtD
Goserelin—Asthenia—Docetaxel—skin cancer	0.000378	0.000501	CcSEcCtD
Goserelin—Pruritus—Docetaxel—skin cancer	0.000373	0.000494	CcSEcCtD
Goserelin—Diarrhoea—Docetaxel—skin cancer	0.00036	0.000477	CcSEcCtD
Goserelin—Dizziness—Docetaxel—skin cancer	0.000348	0.000461	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—NRAS—skin cancer	0.000338	0.00197	CbGpPWpGaD
Goserelin—Vomiting—Docetaxel—skin cancer	0.000335	0.000444	CcSEcCtD
Goserelin—Rash—Docetaxel—skin cancer	0.000332	0.00044	CcSEcCtD
Goserelin—Dermatitis—Docetaxel—skin cancer	0.000332	0.00044	CcSEcCtD
Goserelin—Headache—Docetaxel—skin cancer	0.00033	0.000437	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—BRAF—skin cancer	0.000317	0.00185	CbGpPWpGaD
Goserelin—Nausea—Docetaxel—skin cancer	0.000313	0.000414	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—KRAS—skin cancer	0.000291	0.00169	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TERT—skin cancer	0.000268	0.00156	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—HRAS—skin cancer	0.000247	0.00144	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—skin cancer	0.000236	0.00138	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—NRAS—skin cancer	0.000226	0.00132	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—BRAF—skin cancer	0.000212	0.00124	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NRAS—skin cancer	0.000199	0.00116	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—KRAS—skin cancer	0.000194	0.00113	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KRAS—skin cancer	0.000172	0.001	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HRAS—skin cancer	0.000165	0.000964	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—skin cancer	0.000158	0.000922	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TP53—skin cancer	0.000153	0.000889	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HRAS—skin cancer	0.000146	0.00085	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—skin cancer	0.00014	0.000814	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NRAS—skin cancer	0.000133	0.000778	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KRAS—skin cancer	0.000115	0.00067	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TP53—skin cancer	0.000102	0.000595	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HRAS—skin cancer	9.77e-05	0.000569	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—skin cancer	9.35e-05	0.000545	CbGpPWpGaD
